蒲公英 - 制药技术的传播者 GMP理论的实践者

搜索
查看: 1800|回复: 5
收起左侧

[FDA药事] FDAcGMP检查将实施评分系统

[复制链接]
药生
发表于 2015-1-7 14:14:26 | 显示全部楼层 |阅读模式

欢迎您注册蒲公英

您需要 登录 才可以下载或查看,没有帐号?立即注册

x
评分系统: 1. 严重故障,2. 重大故障,3. 轻微故障,4. 可接受,5. 超过 6.优越。


FDA Considers New Inspection Scoring System


The system, which hasn’t been finalized, would offer drugmakers six scores: critical failure, major failure, minor failure, acceptable, exceeds and superior. Drugmakers would receive a score for each aspect of an inspection, including whether a facility meets GMPs, has an adequate quality system and quality culture.


The proposed system is part of an inspections protocol project that is intended to revamp the inspection process so CDER gets a better idea of a facility’s state of quality.


The scores would be given in addition to the traditional overall classifications: no action indicated, voluntary action indicated and official action indicated, Neil Stiber, CDER senior operations research analyst, told DGR after a session at the Parenteral Drug Association’s quality metrics conference last month.


Scores to Provide More Information


The scores are intended to provide more information to drugmakers than the broad classifications, and won’t interfere with the process for levying enforcement actions such as Form 483s, Stiber said. The scores also wouldn’t directly translate into an inspection classification such as NAI, OAI or VAI.


Inspection classifications depend on many factors, including prior issues, drug availability and how well the facility responded to problems previously, he said. Those issues will still help determine the inspectional outcome.


A goal of the scoring system would be to recognize manufacturers that go beyond meeting agency regulations and GMPs. The scoring system would also provide more specific feedback on inspection results than the broad, overall classifications, Stiber said.


Any score also would be in addition to the upcoming ranking that a facility will receive based on a series of quality metrics. The rankings will be used to compare manufacturers to the rest of industry and determine inspection frequency.

回复

使用道具 举报

发表于 2015-1-7 15:04:05 | 显示全部楼层
谁能翻译一下
回复

使用道具 举报

药生
发表于 2015-1-7 15:40:29 | 显示全部楼层
这是要向天朝学

点评

我们有这种等级评定么?  详情 回复 发表于 2015-1-7 21:22
回复

使用道具 举报

药生
发表于 2015-1-7 20:12:42 | 显示全部楼层
这个可以看看。  
回复

使用道具 举报

药生
发表于 2015-1-7 21:22:02 | 显示全部楼层
胜利者 发表于 2015-1-7 15:40
这是要向天朝学

我们有这种等级评定么?   
回复

使用道具 举报

药徒
发表于 2015-1-9 09:29:40 | 显示全部楼层
故障?应当是缺陷吧。
回复

使用道具 举报

您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

×发帖声明
1、本站为技术交流论坛,发帖的内容具有互动属性。您在本站发布的内容:
①在无人回复的情况下,可以通过自助删帖功能随时删除(自助删帖功能关闭期间,可以联系管理员微信:8542508 处理。)
②在有人回复和讨论的情况下,主题帖和回复内容已构成一个不可分割的整体,您将不能直接删除该帖。
2、禁止发布任何涉政、涉黄赌毒及其他违反国家相关法律、法规、及本站版规的内容,详情请参阅《蒲公英论坛总版规》。
3、您在本站发表、转载的任何作品仅代表您个人观点,不代表本站观点。不要盗用有版权要求的作品,转贴请注明来源,否则文责自负。
4、请认真阅读上述条款,您发帖即代表接受上述条款。

QQ|手机版|蒲公英|ouryao|蒲公英 ( 京ICP备14042168号-1 )  增值电信业务经营许可证编号:京B2-20243455  互联网药品信息服务资格证书编号:(京)-非经营性-2024-0033

GMT+8, 2025-9-27 12:32

Powered by Discuz! X3.4

Copyright © 2001-2020, Tencent Cloud.

声明:蒲公英网站所涉及的原创文章、文字内容、视频图片及首发资料,版权归作者及蒲公英网站所有,转载要在显著位置标明来源“蒲公英”;禁止任何形式的商业用途。违反上述声明的,本站及作者将追究法律责任。
快速回复 返回顶部 返回列表